Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Klinique Medical Clinic PCLBKK:KLINIQ 90 5-Year Yield-on-Cost % is 5.32 as of Jul. 30, 2026, which is 16% above its 10-year median of 4.59. GuruFocus rates BKK:KLINIQ with a GF Score™ of 90/100 and a GF Value™ of ฿44.59 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 46 Personal Services companies, The Klinique Medical Clinic PCL ranks better than 80.43% on this metric.
The historical rank and industry rank for The Klinique Medical Clinic PCL's 5-Year Yield-on-Cost % or its related term are showing as below:
BKK:KLINIQ'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.3 Med: 4.59 Max: 7.32
Current: 5.32
During the past 7 years, The Klinique Medical Clinic PCL's highest Yield on Cost was 7.32. The lowest was 1.30. And the median was 4.59.
BKK:KLINIQ's 5-Year Yield-on-Cost % is ranked better than 80.43% of 46
companies
in the Personal Services industry
Industry Median: 3.565
vs BKK:KLINIQ: 5.32
The Klinique Medical Clinic PCL (BKK:KLINIQ) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
The Klinique Medical Clinic PCL 5-Year Yield-on-Cost % Related Terms
BKK:KLINIQ vs ROL, SCI, HRB: 5-Year Yield-on-Cost % Comparison
For the Personal Services subindustry, The Klinique Medical Clinic PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Klinique Medical Clinic PCL 5-Year Yield-on-Cost % vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, The Klinique Medical Clinic PCL's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where The Klinique Medical Clinic PCL's 5-Year Yield-on-Cost % falls into.
The Klinique Medical Clinic PCL 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a 5-Year Yield-on-Cost % of 5.32 as of Jul. 30, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on The Klinique Medical Clinic PCL and its competitors. This is 16% above median its historical median of 4.59. Over the past decade, The Klinique Medical Clinic PCL's 5-Year Yield-on-Cost % has ranged from 1.30 to 7.32. According to the industry distribution chart, The Klinique Medical Clinic PCL ranks #9 out of 46 companies in the Personal Services industry, placing it in the top 19.6%.
Is The Klinique Medical Clinic PCL's 5-Year Yield-on-Cost % too high?
The Klinique Medical Clinic PCL's current 5-Year Yield-on-Cost % of 5.32 is 16% above median its 10-year median of 4.59. Over the past 10 years, this metric has ranged from a low of 1.30 to a high of 7.32. The Personal Services industry median 5-Year Yield-on-Cost % is 3.57. The Klinique Medical Clinic PCL's value of 5.32 is 49.2% above this industry median. Based on the distribution chart, The Klinique Medical Clinic PCL ranks #9 out of 46 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's 5-Year Yield-on-Cost % compare to ROL and SCI?
According to the Personal Services industry distribution chart, The Klinique Medical Clinic PCL ranks #9 out of 46 companies for 5-Year Yield-on-Cost %. This places The Klinique Medical Clinic PCL in the top 20% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.57. The Klinique Medical Clinic PCL's value of 5.32 is 49.2% above this benchmark. Historically, The Klinique Medical Clinic PCL's own 5-Year Yield-on-Cost % has ranged from 1.30 to 7.32 over the past decade. While the company's 10-year median is 4.59 vs. the industry median of 3.57, The Klinique Medical Clinic PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Personal Services company?
The median 5-Year Yield-on-Cost % among Personal Services companies is 3.57, based on 46 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Klinique Medical Clinic PCL's current 5-Year Yield-on-Cost % of 5.32 is 49.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on The Klinique Medical Clinic PCL and its competitors. For the Personal Services industry, the median 5-Year Yield-on-Cost % is 3.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current 5-Year Yield-on-Cost % is 5.32, which is 16% above median its own 10-year median of 4.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿44.59, compared to a current price of ฿27.25 — trading 38.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 5.32, which is 16% above median its 10-year median of 4.59 and 49.2% above the Personal Services industry median of 3.57. The Klinique Medical Clinic PCL's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current 5-Year Yield-on-Cost % is 5.32 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued.
The current stock price of ฿27.25 is trading 38.9% below its estimated GF Value™ of ฿44.59.
GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.
Key valuation signals for BKK:KLINIQ:
5-Year Yield-on-Cost %: 5.32 (16% above median its 10-year median of 4.59)
GF Value™: ฿44.59 vs. price of ฿27.25 (38.9% below fair value)
Industry Position: 49.2% above the Personal Services median (#9 of 46)
No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Klinique Medical Clinic PCL Business Description
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
90GF Score
Get the complete analysis for BKK:KLINIQ
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KLINIQ has been successfully added to your 
